1 domain / 2 areas / 1 specialization
Iter Investments
Data updated
Iter Investments is a venture capital firm focused on emerging companies developing alternative therapeutics for behavioral and mental health, with a stated emphasis on the psychedelic ecosystem. The firm’s public materials describe it as a Florida-based investor, with headquarters in South Florida.
Iter matters in the psychedelic ecosystem because it backs companies across the sector’s value chain, including drug development, clinics, digital platforms, and supporting infrastructure. Its public portfolio includes Psygen, Awakn Life Sciences, Wesana, PsyTech, and Nucleus-related ecosystem assets, showing a broad strategy beyond a single therapeutic modality.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Pre-Seed, Seed, and Series A/B. Public focus areas include Drug Development, Clinical Infrastructure, and Digital Therapeutics & Platforms.
Public Portfolio Examples
- PsygenPortfolio investment
- Awakn Life SciencesPortfolio investment
Iter Investments presents itself as a venture capital firm investing across the psychedelic and alternative therapeutics landscape, with interests spanning drug development, clinical delivery, digital therapeutics, and ecosystem infrastructure. Public portfolio materials show exposure to pharmaceutical inputs, clinical operators, software and community platforms, and media/data assets tied to the psychedelic market.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Recorded Investments
Quick Facts
- Founded
- 2021
- HQ
- South Florida, United States
- Website
- Visit